Corona Remedies has announced its Initial Public Offering (IPO) and is expected to be listed soon. The IPO opened on Dec 8, 2025 and will close on Dec 10, 2025. The price band has been set at ₹1008.00-1062.00.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | -1.93 | 6.54 | 13.61 | 6.97 | -0.48 | 20.23 | 25.27 |
| Divi's Laboratories | -2.29 | -8.06 | 4.99 | -3.3 | 3.23 | 23.55 | 11.23 |
| Torrent Pharmaceuticals | 1.06 | 5.81 | 4.07 | 19.2 | 12.83 | 32.53 | 22.82 |
| Cipla | -2.2 | -0.26 | -2.83 | -0.44 | 1.37 | 10.51 | 14.14 |
| Dr. Reddy's Laboratories | 0.61 | 5.09 | 1.27 | -4.12 | 1.02 | 13.13 | 4.72 |
| Lupin | -0.55 | 5.89 | 6.34 | 3.56 | -2.95 | 39.2 | 16.44 |
| Zydus Lifesciences | -1.9 | -1.29 | -8.42 | -3.7 | -7.08 | 31.12 | 14.39 |
| Mankind Pharma | -2.91 | -5.35 | -15.27 | -7.09 | -15.5 | 15.39 | 8.97 |
| Aurobindo Pharma | -4.02 | 3.23 | 13.19 | 1.4 | -5.52 | 36.22 | 5.29 |
| Alkem Laboratories | -1.51 | -0.79 | 4.99 | 15.15 | 1.7 | 21.76 | 13.9 |
| Abbott India | -4.49 | -2.48 | -7.23 | -9.18 | -1.07 | 12.46 | 13.44 |
| Glenmark Pharmaceuticals | -1.25 | 6.16 | -6.34 | 20.86 | 25.77 | 65.35 | 29.28 |
| Laurus Labs | -2.64 | 2.48 | 12.16 | 56.39 | 70.26 | 33.75 | 24.77 |
| Biocon | -3.65 | -0.36 | 5.4 | 16.29 | 0.99 | 11.93 | -3.16 |
| GlaxoSmithKline Pharmaceuticals | -0.98 | -2.35 | -9.75 | -26.01 | 8.58 | 24.2 | 10.4 |
| Ipca Laboratories | -0.37 | 10.95 | 9.64 | 5.6 | -5.88 | 19.08 | 5.46 |
| Anthem Biosciences | 2.24 | -6.85 | -20.49 | -11.15 | -11.15 | -3.86 | -2.34 |
| Ajanta Pharma | 3.81 | 3.48 | 2.61 | 3.38 | -7.21 | 29.12 | 18.87 |
| J B Chemicals & Pharmaceuticals | 1.84 | 6.63 | 4.56 | 5.97 | 2.26 | 21.11 | 29.15 |
Corona Remedies Ltd. is a Public Limited Listed company incorporated on 27/08/2004 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24231GJ2004PLC044656 and registration number is 044656. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1196.42 Cr. and Equity Capital is Rs. 61.16 Cr. for the Year ended 31/03/2025.